Fosun Pharma and its partner BioNTech are conducting a coronavirus vaccine trial in China. Photo: ReutersFosun Pharma and its partner BioNTech are conducting a coronavirus vaccine trial in China. Photo: Reuters
Fosun Pharma and its partner BioNTech are conducting a coronavirus vaccine trial in China. Photo: Reuters

Coronavirus: Fosun Pharma, BioNTech’s China vaccine trial is an important step before securing marketing approval, companies say

  • 144 participants in mainland China will receive two shots of the BNT162b1 coronavirus vaccine candidate spaced by 21 days
  • BioNTech among the first international biopharmaceutical companies to start clinical trial of a Covid-19 vaccine candidate in China

Topic |   Coronavirus pandemic
Fosun Pharma and its partner BioNTech are conducting a coronavirus vaccine trial in China. Photo: ReutersFosun Pharma and its partner BioNTech are conducting a coronavirus vaccine trial in China. Photo: Reuters
Fosun Pharma and its partner BioNTech are conducting a coronavirus vaccine trial in China. Photo: Reuters
READ FULL ARTICLE
Close
We need your support

Advertising helps us continue to provide quality content. Help support us by disabling your adblocker on our site.

How to whitelist us:
  1. 1
    Click on the AdBlock icon at the top right corner of your browser.
    For iOS, go to Settings/Safari/Content Blockers and turn it off.

    For Android, go to your Ad blocker app/Settings and turn it off.
  2. 2
    Click Enabled on this site until the text reads Disabled on this site.
  3. 2
    Click the cross icon on the top right corner to close this window and refresh the page.
  4. 3
    Click the cross icon on the top right corner to close this window and refresh the page.